XIAMEN CIYUAN BIOTECH CO., LTD Magnetic drug nano-particles, Anti-cancer new drug, Multi-carrier, Multi-target range, Multi-target point, Postpone controlled release, Reversion of multi-drug resistance, Two cure ways by oral and nasal cavity. Our 10 new innovation drugs (such as Anti-Cancer, Anti-Aids, Anti-Dengue, Anti-Malaria, Anti-cerebral thrombus etc) were successful completion of the first time pilot plant test, now looking for investment and cooperation, technology transfer. The sample of this Anti-Cancer (Broad Spectrum), was sent to authoritative government department for testing, After inside coelom test of white rat, the test results were: 99.3% for cancer restraint rate of cervical cancer U14, The result for toxicity test was: Maximum Tolerated Dose (TMD) is 35.2g/kg, equal 352 times of the clinical human dosage. The samples of pilot plant test were passed clinical preliminary test by more 20 patients, the preliminary verification of this clinical preliminary test: definite efficacy, higher security, and less side-effects.